Previous studies [38–40] have suggested that the molecular signature of NFE2L2 (NRF2), a master transcriptional regulator of stress response, serves as a predictive marker for esophageal tumor response to CCRT. Here, NFE2L2 is linked to neoplasm of esophagus.